Treatment for Acute Anxiety in Dementia

Introduction to Treatment Approaches

The American Geriatrics Society recommends a stepped approach for acute anxiety in dementia, starting with non-pharmacological interventions, followed by short-term use of SSRIs if needed, and reserving benzodiazepines for severe, acute episodes due to their significant risks 1, 2

Identify and address underlying causes of anxiety, such as pain, discomfort, environmental triggers, or unmet needs, as recommended by the American Geriatrics Society 1
Behavioral strategies, including the "three R's" approach (repeat, reassure, and redirect), can be used to manage anxiety episodes, as suggested by the American Academy of Family Physicians 3
Environmental modifications, such as reducing excess stimulation and maintaining consistent routines, can help manage anxiety in dementia patients, according to the American Academy of Family Physicians 3
Caregiver education on effective communication techniques and behavioral management strategies is crucial, as recommended by the American Geriatrics Society 1

The American Academy of Family Physicians recommends citalopram (Celexa) as a first-choice medication, starting at 10 mg daily, with a maximum dose of 40 mg daily 4, 3
Sertraline (Zoloft) is also recommended, starting at 25-50 mg daily, with a maximum dose of 200 mg daily, by the American Academy of Family Physicians 4, 3
SSRIs are preferred due to their significant improvement in overall neuropsychiatric symptoms and agitation in dementia, with minimal anticholinergic side effects, as stated by the Alzheimer's Association 2 and the American Academy of Family Physicians 3

The American Academy of Family Physicians recommends short-acting benzodiazepines, such as lorazepam (Ativan) or oxazepam (Serax), for severe, acute anxiety episodes, but with extreme caution due to significant risks in elderly dementia patients, including sedation, cognitive impairment, falls, and paradoxical agitation 4, 5, 6
The Mayo Clinic recommends using the lowest possible dose for the shortest duration (ideally less than 2 weeks) and avoiding regular use due to tolerance, addiction, and worsening cognitive impairment 6

The Alzheimer's Association and the Mayo Clinic recommend avoiding antipsychotics, both typical and atypical, due to FDA black box warnings for increased mortality risk in dementia patients 2, 6
Anticholinergic medications should be avoided, as they can worsen cognition and increase confusion, according to the Mayo Clinic 6
Long-acting benzodiazepines, such as diazepam, should be avoided due to accumulation in elderly patients and increased risk of adverse effects, as recommended by the Mayo Clinic 6

The American Geriatrics Society recommends cognitive interventions applying principles of reality orientation, cognitive stimulation, and/or reminiscence therapy for anxiety associated with dementia 7

Selective serotonin reuptake inhibitors (SSRIs) are preferred for treating anxiety associated with dementia due to significant improvement in neuropsychiatric symptoms including anxiety, with minimal anticholinergic side effects and a better safety profile in elderly patients 8

The American Geriatrics Society suggests assessing effectiveness of treatment at 4-6 weeks, and using validated assessment tools to quantify anxiety symptoms 9
The Lancet Healthy Longevity recommends using validated assessment tools to quantify anxiety symptoms, and notes that depression often co-occurs with anxiety in dementia and should be assessed 10
The American Geriatrics Society recommends attempting medication tapering every 6 months to assess continued need, and notes that regular social activities and meaningful engagement may help reduce anxiety symptoms 11